METTL1 and neoplasm: While Docetaxel treatment induced a modest growth reduction in wild-type tumours (Fig. 7A), it significantly reversed the growth and reduced the size of METTL1-KO tumours, almost to the initial stages of tumour formation (Fig. 7B).